Evidence map›Paper›PMID 38081956›Full record

ArticleScientific reports2023

Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach.

Satoshi Kozawa, Kengo Tejima, Shunki Takagi, Masataka Kuroda, Mari Nogami-Itoh, Hideya Kitamura, Takashi Niwa, Takashi Ogura, Yayoi Natsume-Kitatani, Thomas N Sato

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Investigating the Role of KNG1 in Traumatic Brain Injury.Journal of inflammation research · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Satoshi Kozawa *Karydo TherapeutiX, Inc., 2-2-2 Hikaridai, Seika-Cho, Soraku-Gun, Kyoto, 619-0288, Japan.
Kengo Tejima *Karydo TherapeutiX, Inc., 2-2-2 Hikaridai, Seika-Cho, Soraku-Gun, Kyoto, 619-0288, Japan.
Shunki Takagi *Karydo TherapeutiX, Inc., 2-2-2 Hikaridai, Seika-Cho, Soraku-Gun, Kyoto, 619-0288, Japan.
Masataka KurodaNational Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Mari Nogami-ItohNational Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Hideya KitamuraKanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
Takashi NiwaKanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
Takashi OguraKanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan.
Yayoi Natsume-KitataniNational Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Thomas N SatoKarydo TherapeutiX, Inc., 2-2-2 Hikaridai, Seika-Cho, Soraku-Gun, Kyoto, 619-0288, Japan. island1005@gmail.com.
Advanced Telecommunications Research Institute International · JPKanagawa Cardiovascular and Respiratory Center · JPNational Institute of Biomedical Innovation, Health and Nutrition · JP

Funding

Innovative Science and Technology Initiative for Security JPJ004596 ATLA JapanMHLW Health, Labour and Welfare Sciences Research Grants Program JPMH20AC5001
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disease characterized by complex lung pathogenesis affecting approximately three million people worldwide. While the molecular and cellular details of the IPF mechanism is emerging, our current understanding is centered around the lung itself. On the other hand, many human diseases are the products of complex multi-organ interactions. Hence, we postulate that a dysfunctional crosstalk of the lung with other organs plays a causative role in the onset, progression and/or complications of IPF. In this study, we employed a generative computational approach to identify such inter-organ mechanism of IPF. This approach found unexpected molecular relatedness of IPF to neoplasm, diabetes, Alzheimer's disease, obesity, atherosclerosis, and arteriosclerosis. Furthermore, as a potential mechanism underlying this relatedness, we uncovered a putative molecular crosstalk system across the lung and the liver. In this inter-organ system, a secreted protein, kininogen 1, from hepatocytes in the liver interacts with its receptor, bradykinin receptor B1 in the lung. This ligand-receptor interaction across the liver and the lung leads to the activation of calmodulin pathways in the lung, leading to the activation of interleukin 6 and phosphoenolpyruvate carboxykinase 1 pathway across these organs. Importantly, we retrospectively identified several pre-clinical and clinical evidence supporting this inter-organ mechanism of IPF. In conclusion, such feedforward and feedback loop system across the lung and the liver provides a unique opportunity for the development of the treatment and/or diagnosis of IPF. Furthermore, the result illustrates a generative computational framework for machine-mediated synthesis of mechanisms that facilitates and complements the traditional experimental approaches in biomedical sciences.

Indexed as

Idiopathic Pulmonary FibrosisHumansLungRetrospective Studies

Identifiers

PMID38081956
PMCPMC10713585
OpenAlexW4389574393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.